GO
Loading...

Merck CFO to Retire in July

Merck said Chief Financial Officer Judy Lewent, 58, plans to retire in July after 17 years in the post.

The drugmaker, which has seen its fortunes greatly improve over the past two years in the aftermath of the 2004 withdrawal of the company's blockbuster Vioxx arthritis drug, said Lewent has played a leading role in the "resurgence of Merck's corporate development" and licensing of drugs from other drugmakers.

Contact U.S. News

  • CNBC NEWSLETTERS

    Get the best of CNBC in your inbox

    › Learn More

Don't Miss

U.S. Video

  • CNBC's Rick Santelli weighs in on the impact Bill Gross had on Pimco and looks forward to future performance of the institution.

  • Discussing Pimco's future in equities and if investors will leave for Janus, with Tim Maurer, BAM Alliance, and Ric Edelman, Edelman Financial Services.

  • CNBC's Brian Sullivan asks Pimco CEO Doug Hodge about the future of the equities business at Pimco. Hodge says growing active equities is an important part of the way forward.